Changes in plasma protein binding have little clinical relevance

被引：566

作者：

Benet, LZ ^{[1
]}

Hoener, BA ^{[1
]}

机构：

[1] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 03期

关键词：

D O I：

10.1067/mcp.2002.121829

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：115 / 121

页数：7

相关论文

共 20 条

[1] POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE
AGGELER, PM
OREILLY, RA
LEONG, L
KOWITZ, PE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) : 496 - &
[2] PHENYLBUTAZONE-WARFARIN INTERACTION IN MAN - FURTHER STEREOCHEMICAL AND METABOLIC CONSIDERATIONS
BANFIELD, C
OREILLY, R
CHAN, E
ROWLAND, M
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) : 669 - 675
[3] CHRISTENSEN LK, 1963, LANCET, V2, P1298
[4] FOX SL, 1964, JAMA-J AM MED ASSOC, V188, P320
[5] Gilman, 1996, GOODMAN GILMANS PHAR, P1707
[6] UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS
HOLFORD, NHG
SHEINER, LB
[J]. CLINICAL PHARMACOKINETICS, 1981, 6 (06) : 429 - 453
[7] HOLFORD NHG, 1995, BASIC CLIN PHARM, P33
[8] PROTEIN-BINDING DRUG DISPLACEMENT INTERACTIONS - FACT OR FICTION
MACKICHAN, JJ
[J]. CLINICAL PHARMACOKINETICS, 1989, 16 (02) : 65 - 73
[9] PLASMA-PROTEIN BINDING DISPLACEMENT INTERACTIONS - WHY ARE THEY STILL REGARDED AS CLINICALLY IMPORTANT
ROLAN, PE
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (02) : 125 - 128
[10] CLEARANCE CONCEPTS IN PHARMACOKINETICS
ROWLAND, M
BENET, LZ
GRAHAM, GG
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (02): : 123 - 136